These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15599103)

  • 1. New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application.
    Fujiwara M; Egashira N
    J Pharmacol Sci; 2004 Dec; 96(4):362-6. PubMed ID: 15599103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.
    Mallet PE; Beninger RJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):11-9. PubMed ID: 9862397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
    Carta G; Nava F; Gessa GL
    Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
    Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
    Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
    Sano K; Mishima K; Koushi E; Orito K; Egashira N; Irie K; Takasaki K; Katsurabayashi S; Iwasaki K; Uchida N; Egawa T; Kitamura Y; Nishimura R; Fujiwara M
    Neuroscience; 2008 Jan; 151(2):320-8. PubMed ID: 18083311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SR 141716A differentially attenuates the behavioral effects of delta9-THC in rhesus monkeys.
    McMahon LR; Amin MR; France CP
    Behav Pharmacol; 2005 Sep; 16(5-6):363-72. PubMed ID: 16148440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
    Pryce G; Riddall DR; Selwood DL; Giovannoni G; Baker D
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):281-92. PubMed ID: 25537576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.
    Zimmer A; Zimmer AM; Hohmann AG; Herkenham M; Bonner TI
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5780-5. PubMed ID: 10318961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
    Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
    J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior.
    Dahlén A; Zarei M; Melgoza A; Wagle M; Guo S
    Sci Rep; 2021 Aug; 11(1):15693. PubMed ID: 34344922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
    Mishima K; Egashira N; Matsumoto Y; Iwasaki K; Fujiwara M
    Life Sci; 2002 Dec; 72(4-5):397-407. PubMed ID: 12467880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
    Cox ML; Welch SP
    Eur J Pharmacol; 2004 Jun; 493(1-3):65-74. PubMed ID: 15189765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
    Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats.
    Egashira N; Ishigami N; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):499-506. PubMed ID: 18029074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CB
    Joffre J; Yeh CC; Wong E; Thete M; Xu F; Zlatanova I; Lloyd E; Kobzik L; Legrand M; Hellman J
    J Immunol; 2020 Jun; 204(12):3339-3350. PubMed ID: 32385136
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
    Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro.
    Whalley BJ; Wilkinson JD; Williamson EM; Constanti A
    Neurosci Lett; 2004 Jul; 365(1):58-63. PubMed ID: 15234473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic memory of Δ9-tetrahydrocannabinol exposure in pluripotent stem cells and primordial germ cells-like cells.
    Verdikt R; Armstrong AA; Cheng J; Hwang YS; Clark AT; Yang X; Allard P
    Elife; 2023 Dec; 12():. PubMed ID: 38150302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.